Description:
The Company is a leading manufacturer of ultra-low temperature electric cryotherapy systems with nearly a decade of industry experience. Renowned for its state-of-the-art electric cryotherapy solutions, the Company’s innovative products and services are recognized for their quality, reliability, and cutting-edge technology, establishing it as a trusted name in the cryotherapy industry.

Key Aspects:
• Consistent Financial Growth: From 2021 to the trailing twelve months (TTM) ending June 30, 2024, the Company's revenue grew at a compound annual growth rate (CAGR) of 5.6%, excluding one-time income.
• Industry Leadership: Established as a leader in the cryotherapy industry, the Company leverages over a decade of specialized experience in ultra-low temperature systems and cryotherapy chambers.
• Diverse Revenue Streams: Revenue is generated through multiple channels, including the sale, installation, and servicing of cryotherapy chambers, all supported by long-term, exclusive contracts with key clients.
• Recurring Revenue Model: Benefiting from service contracts, extended warranties, and maintenance agreements, the Company ensures financial stability and strong customer retention.
• Award-Winning Growth: Recognized as one of the Inc. 5000 fastest-growing private companies for three consecutive years, most recently in 2023, highlighting its consistent growth and market success.

Opportunities:
• Expanding Geographic Reach: Positioned to grow its market presence internationally, the Company aims to build on its U.S. success and drive further revenue growth through strategic geographic expansion.
• Launching New Product Lines: The Company is developing a new cryotherapy chamber and a separate prototype, both designed to target broader markets with easier, more cost-effective installations. Additionally, the Company is expanding its product lineup with a white-labeled add-on cryo machine, strategically avoiding in-house manufacturing to reduce costs while enhancing its market offerings.
• Strengthening Strategic Partnerships: Leveraging relationships with influential distributors and industry leaders will support market penetration and drive sales growth in targeted regions, according to management.
• Scaling Service Capabilities: Proprietary service software offers an opportunity to scale service efficiency, providing a robust support network for customers across multiple time zones.
• Expanding Recurring Revenue: Growing the recurring revenue model through increased adoption of extended warranties and service subscriptions will offer a reliable income stream and enhance customer loyalty.

Headquartered:
• Western U.S.

Current Markets:
• The Company operates primarily as a business-to-business enterprise, providing state-of-the-art cryotherapy systems for recovery and wellness, with a strong presence in the United States serving the wellness and rehabilitation industries.

Real Estate:
• The Company operates from a single facility that includes both a manufacturing warehouse and an office, totaling 15,000 square feet, leased from an unrelated third party.

Shareholder Ownership:
• The Company is equally owned by two shareholders. One shareholder is open to stepping down or becoming a consultant under the right terms, while the other is flexible, willing to either remain long-term or assist with a transitional period following a sale. The owners are seeking a sale to facilitate global expansion, capitalize on synergies, and ensure a smooth transition for new ownership.